Requires that where a health care professional or professionals require the completion of an allergy checklist or form by the patient, prior to receiving care by such professional or professionals, the checklist or form shall also inquire about the opioid history of such patient.
Summary
Bill S00101 amends the public health law in New York to require healthcare professionals to include an inquiry about a patient's opioid history on any allergy checklist or form that the patient must complete prior to receiving care. This measure aims to inform healthcare providers about a patient's past opioid use, thereby assisting in making more informed diagnostic and treatment decisions, particularly to prevent potential opioid relapses. The bill emphasizes the importance of understanding a patient's opioid history as part of their overall health assessment.
Impact
The implementation of this bill will modify existing public health protocols by mandating the inclusion of opioid history inquiries in patient forms. This change is expected to enhance the ability of healthcare professionals to tailor their treatment approaches based on a patient's specific history with opioids, potentially leading to better patient outcomes and reduced instances of opioid misuse. It does not replace existing requirements related to consulting the prescription monitoring program registry, thereby reinforcing the importance of comprehensive patient evaluations.
Sentiment
The sentiment surrounding Bill S00101 appears to be generally supportive, as it addresses a critical public health issue—opioid addiction and its prevention. Stakeholders in the healthcare community recognize the necessity of understanding a patient's opioid history to provide safe and effective care. However, there may be concerns regarding the administrative burden this requirement could place on healthcare providers and the potential implications for patient privacy.
Contention
Notable points of contention may arise from healthcare professionals who are concerned about the additional workload associated with implementing this new requirement. Some may argue that it could complicate the patient intake process or lead to delays in care. Additionally, there may be discussions regarding how this information will be collected, stored, and utilized, particularly in terms of patient confidentiality and data security.
Same As
Requires that where a health care professional or professionals require the completion of an allergy checklist or form by the patient, prior to receiving care by such professional or professionals, the checklist or form shall also inquire about the opioid history of such patient.
Requires that where a health care professional or professionals require the completion of an allergy checklist or form by the patient, prior to receiving care by such professional or professionals, the checklist or form shall also inquire about the opioid history of such patient.
Requires that where a health care professional or professionals require the completion of an allergy checklist or form by the patient, prior to receiving care by such professional or professionals, the checklist or form shall also inquire about the opioid history of such patient.
Requires health care professionals to prescribe opioid antagonists when prescribing an opioid and discuss the dangers of opioid addiction with such patient in a manner consistent with regulations promulgated by the commissioner of health.
Requires licensed health care professionals providing prenatal care to offer and screen, upon request, pregnant patients with history of depression for postpartum depression.
Requires licensed health care professionals providing prenatal care to offer and screen, upon request, pregnant patients with history of depression for postpartum depression.
Authorizes health care professionals to engage in the use of remote patient monitoring devices; requires health care insurance coverage by certain insurers for remote patient monitoring devices.
Relates to requirements for medical professionals and health care facilities that provide medication to patients for medical aid in dying; extends the initial effectiveness of certain provisions relating thereto.